MitoQ

Pacific AM hires healthcare manager Dani Saurymper for new fund

Latest articles

Drive to end cancer could pioneer diagnostic technology

Blood test that can determine a cancer signal origin with high accuracy is now available on prescription in the US and could lead to...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...

New SIRT6 activator supplement hits the market

Sirtuin 6, the protein making waves in the longevity pool, can now be activated by a brand-new supplement. SIRT6 is a protein with an important...

Most read

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...
fundraising

Editor's picks

Drive to end cancer could pioneer diagnostic technology

Blood test that can determine a cancer signal origin with high accuracy is now available on prescription in the US and could lead to...

Small is mighty when it comes to mitochondria supplements

Optimise, energise, revitalise – MitoQ is on a mission to supplement your mitochondrial health. Coenzyme Q10 – or CoQ10 – is made naturally in the...

Improving speed and accuracy in Alzheimer’s patients

Phase 2a study of patients with Alzheimer's or Parkinson's finds that ANVS401 treatment leads to significant improvement in speed and accuracy. Annovis Bio Inc, a...
MitoQ

Click the globe for translations.

Pacific Asset Management has hired Dani Saurymper from AXA IM – new fund lined up for the healthcare manager.

Pacific Asset Management (PAM) has announced the appointment of Dani Saurymper from AXA IM. Saurymper is set to join PAM in July and will be based in PAM’s new offices at 1 Portland Place, London.

Longevity.Technology: Investing in longevity offers both opportunity and challenge; the global pandemic has focused attention on healthcare, pharma and aging as never before. Healthcare funds involved in healthy aging and delaying age-related decline and disease can make a real difference to lifespan and healthspan outcomes, but there are issues such as clinical trial success likelihoods, getting products safely to market and regulation to consider. An experienced portfolio manager is key to successful investment.

Saurymper is currently portfolio manager for the AXA Framlington Longevity Economy Fund and research lead for Health/Ageing and Lifestyle at AXA IM Framlington Equities. He is also portfolio manager of the AXA Framlington Health Fund and has 20 years’ experience in the healthcare sector. It is anticipated that Pacific Asset Management will launch a new fund for Saurymper to manage in due course.

 


 

“The longevity economy, demographic shifts and social change driven by a gravitation to a more sustainable world, are critical areas for investors in the next decade…”

 


 

Matthew Lamb, CEO, Pacific Asset Management, said: “We have long recognised Dani’s talent and we are thrilled that he has decided to join our team. We have built from scratch a technologically advanced fund management business with a supportive framework which allows our fund managers to follow their conviction and invest where they see the greatest opportunity.

“The longevity economy, demographic shifts and social change driven by a gravitation to a more sustainable world, are critical areas for investors in the next decade. We want to deliver forward-looking strategies for our clients to benefit while supporting these trends. We look forward to welcoming Dani and building his team to support an exciting new global equity proposition at Pacific Asset Management.”

 


 

“Longevity is altering societies globally and is arguably this century’s greatest social, economic and political transformation…”

 


 

Dani Saurymper commented: “I am excited to be joining the team at PAM who share my passion for investing in secular growth themes such as demographics and healthcare. Longevity is altering societies globally and is arguably this century’s greatest social, economic and political transformation. It will have significant implications for how we live and work and what we do once we retire.

“A vast array of industries are set to benefit from an ageing society and by leveraging a responsible investment philosophy, identifying companies with strong ESG credentials that are positioned to benefit from secular tailwinds, we will aim to deliver a unique and differentiated equity value proposition for investors.”

Image courtesy of Dani Saurymper

Comment on this article

Eleanor Garth
Deputy Editor Now a science and medicine journalist, Eleanor worked as a consultant for university spin-out companies and provided research support at Imperial College London and various London hospitals in a former life.
MitoQ

Most popular

New NAD+ boosting longevity supplement hits the market

Elevant Prime dietary supplement contains a “high purity” form of NMN that has completed safety and toxicology testing. New York based health and wellness brand...

David Sinclair to co-chair $200 million biotech SPAC

Christian Angermayer's Frontier Acquisition Corp. holds significant longevity interest with David Sinclair and Peter Attia as Co-Chairs of the Board. Frontier Acquisition Corporation, a special...

Tree of Longevity – understanding how supplements work

Pathways? Hallmarks? Biomarkers? Understanding the longevity supplements lingo can help you make better choices for your healthspan. Longevity supplements differ from other 'generic supplements' as...

Spermidine: the mind-enhancing supplement

Scientists are finding that a high intake of dietary spermidine could slow down (or reverse) the brain aging process. Memory loss and slower brain function...
fundraising

Related articles

Calling all longevity start-ups and scale-ups

Some news from us! Longevity.Technology's brand-new investment portal brings innovators and investors together. As a part of our mission to support the companies that will...

Oisín seed raise advances therapies for diseases of aging

Oisín Biotechnologies funding tops $9.5 million, with additional funding set to support preclinical development of its platform and investigational therapy for kidney and other age-related diseases. Seattle-based...

Dorian and HitGen to collaborate on senotherapy

Send in the senoblockers – Dorian and HitGen announce a research collaboration focused on DNA-encoded library-based drug discovery for age-related diseases. HitGen, Inc today announced...

Angermayer’s $120M for the disease of the century

Investor states that mental health issues will be the "number one disease of the 21st century." Fresh from announcing his involvement in a $200 million...

Dyno Therapeutics closes $100m to accelerate gene therapy

Dyno Therapeutics closes $100 million Series A led by Andreessen Horowitz to accelerate AI-powered gene therapy platform. Dyno Therapeutics, Inc, a biotech applying AI to...
MitoQ